ghk-cu copper peptide cream Face CU peptide products formulated for skin GHK-CU Copper Peptide, Face Cream,

At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable

Se comercializa como reactivo de investigacin y no figura en la lista de sustancias prohibidas de la AEPSAD para deportistas

(n.d.).

and E.S.: data curation

1 Wilding JPH, et al

PMC 2024